According to www.techsciresearch.com latest Report- Global oncology drugs market is projected to grow at a brisk rate over the forecast period owing to widespread prevalence of cancer, globally.
Report URL- https://www.techsciresearch.com/report/oncology-drugs-market/4689.html
Chemotherapy Market Size, Share & Forecast | TechSci Research TechSci Research
According to www.techsciresearch.com latest report- Global Chemotherapy Market By Drugs (Alone, Combination), By Type (Alkylating Agents, Nitrosoureas, Antimetabolites, Anti-tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Corticosteroids, Others), By Indication (Leukaemia, Lymphoma, Hodgkin Disease, Multiple Myeloma, Sarcoma, Bone Marrow Disease, Immune System Disorder), By Route of Administration (Intravenous, Orally, Transdermal, Intraperitoneal, Intrapleural, Intrathecal, Intravesical, Others), By End-User (Hospitals, Specialty Center, Others), By Region, Forecast & Opportunities, 2025.
Report URL- https://www.techsciresearch.com/report/chemotherapy-market/4735.html
Japan generics drug market outlook 2020Rajesh Sarma
“Japan Generics Drug Market Outlook 2020” Report Highlights:
Introduction to Japanese Generic Drug Market
Attractiveness of Japanese Generic Market
Super Generics in Japan
Japan Healthcare System & Generic Drugs
Different Parameters for Generic & Branded Drugs
Comparison of Generic Drugs in US & Japan
Japan Generics Drug Market Analysis
Japan Generics Drug Market Future Prospects
Canada Cannabis for GI Disease Market ReportInsights10
Medical cannabinoid products are widely used in Canada to treat medical symptoms of all kinds, and gastrointestinal (GI) symptoms are among the most commonly cited reasons for use. Cannabis is also widely used recreationally, and legalization of recreational use has occurred in Canada. Cannabis can be beneficial for individuals taking opioid medications for abdominal pain. Research shows that cannabis helps patients cut down on or eliminate their need for opioids and provides treatment with fewer side effects. Cannabis also helps individuals who have difficulty eating enough by increasing appetite and can help reduce diarrhoea and nausea.
Key factors supporting the growth are rise in prevalence of cannabis intake for GI disease. The need to develop better product delivery systems and sustainable product strains. This need has, in turn, led to many companies coming up with R&D, which extensively investigates several genetic improvement strategies for cannabis. While the public opinion of cannabis has gone through many shifts, public interest in Canada has continued to grow in recent years. With the legalization of cannabis in Canada and more research, people are getting a deeper understanding of how cannabis works in humans.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us at info@insights10.com
Rising prevalence of breast cancer pertaining to factors such as prolonged exposure to endogenous oestrogens, early menarche, late age at first childbirth and late menopause will be a high impact rendering factor for the industry growth. Increasing technological advances in cancer biology and launch of several diagnostic and screening programs worldwide should drive the business size. Growing adoption of therapeutics owing to factors such as blocking estrogenic from binding to tumour cells, risk of distant reappearance, lowering jeopardy of reappearance in the breast that had tumour and reducing risk of developing disease in another breast will propel the industry growth.
Growing awareness regarding breast cancer, rising shift towards adoption of western lifestyle, short breast-feeding timeframe and rising prevalence of obesity in women after menopause will drive the industry size. Increasing rate of alcohol consumption in women, rising use of hormone replacement therapy (HRT) and oral birth control pills resulting in increased levels of oestrogen will boost the business size over the forecast period. Growing exposure to certain carcinogens and endocrine disruptors, for example in the workplace, working night shifts results in increased risk are surging up the U.S. market
Prohibitive cost associated with the use of breast cancer therapeutics may hamper the industry growth. Increasing cost of early and late-stage disease therapy, continuing care on a per-unit time basis, accounting for the major share of lifetime cost owing to relatively extended survival of breast cancer patients may further restrain the business growth
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us at info@insights10.com
Epigenetics Diagnostic Market Size, Share, Growth, Trends and Forecast Report...Signitech
The global epigenetics diagnostic market size was valued at USD 5.5 billion in 2018 and is estimated to register a CAGR of 18.8% over the forecast period. Increasing prevalence of cancer and other chronic diseases and growing geriatric population are some of the key factors expected to drive the market.
Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder that impacts an individual ability to focus, self-control, and perform other skills important in daily life. ADHD is caused due to biochemical, connectivity, and the structural difference in the mind. Symptoms of Attention Deficit Hyperactivity Disorder (ADHD) mostly advances over a period and vary according to the type of causing factor and according to the age group of the person. The common symptoms in patient population are trouble at work, low self-esteem and substance abuse or ADHD, low-stress tolerance level, mood swings, and many more. Further, based on symptoms, ADHD is classified into three key categories including the predominantly inattentive, predominantly hyperactive-impulsive, and combined type. ADHD is diagnosed using a comprehensive evaluation of the patient’s mental and behavioral condition. Various treatment options are pharmacological treatment, educational interventions & other behavioral therapies, and EEG biofeedback therapies, physicians could reduce the disorder symptoms and their effects on the individual health.
The global attention deficit hyperactivity disorder (ADHD) market is expected to grow with increasing pharmaceutical R&D spending, growing healthcare expenditure, accelerating economic growth, unmet treatment needs, and mounting occurrence of ADHD. Key trends and developments of this market include progressing drugs under pipeline, high demand for dual therapy, and rising preference for EEG biofeedback therapy. However, there are some factors that can hinder the growth of the market including Medical complications of existing drug therapies, high domination of the generic pharmaceutical market, and strict government protocols
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us at info@insights10.com
Medical Marijuana Market Size, Share, Trends and Growth Analysis Research, 20...Signitech
The global medical marijuana market size was valued at USD 11.4 billion in 2015 and is projected to grow with CAGR of 17.1% during the forecast period.
NON-ALCOHOLIC STEATOHEPATITIS (NASH): AN ANALYSIS OF DISEASE PREVALENCE, DRUG...MP ADVISORS
This report will provide detailed analysis on NASH disease and Drugs in development in broader pharma market. This report list all the drugs in clinical trial and their design and the population recruited, also tells about the pathways representing possible targets for the treatment of NASH
Chemotherapy Market Size, Share & Forecast | TechSci Research TechSci Research
According to www.techsciresearch.com latest report- Global Chemotherapy Market By Drugs (Alone, Combination), By Type (Alkylating Agents, Nitrosoureas, Antimetabolites, Anti-tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Corticosteroids, Others), By Indication (Leukaemia, Lymphoma, Hodgkin Disease, Multiple Myeloma, Sarcoma, Bone Marrow Disease, Immune System Disorder), By Route of Administration (Intravenous, Orally, Transdermal, Intraperitoneal, Intrapleural, Intrathecal, Intravesical, Others), By End-User (Hospitals, Specialty Center, Others), By Region, Forecast & Opportunities, 2025.
Report URL- https://www.techsciresearch.com/report/chemotherapy-market/4735.html
Japan generics drug market outlook 2020Rajesh Sarma
“Japan Generics Drug Market Outlook 2020” Report Highlights:
Introduction to Japanese Generic Drug Market
Attractiveness of Japanese Generic Market
Super Generics in Japan
Japan Healthcare System & Generic Drugs
Different Parameters for Generic & Branded Drugs
Comparison of Generic Drugs in US & Japan
Japan Generics Drug Market Analysis
Japan Generics Drug Market Future Prospects
Canada Cannabis for GI Disease Market ReportInsights10
Medical cannabinoid products are widely used in Canada to treat medical symptoms of all kinds, and gastrointestinal (GI) symptoms are among the most commonly cited reasons for use. Cannabis is also widely used recreationally, and legalization of recreational use has occurred in Canada. Cannabis can be beneficial for individuals taking opioid medications for abdominal pain. Research shows that cannabis helps patients cut down on or eliminate their need for opioids and provides treatment with fewer side effects. Cannabis also helps individuals who have difficulty eating enough by increasing appetite and can help reduce diarrhoea and nausea.
Key factors supporting the growth are rise in prevalence of cannabis intake for GI disease. The need to develop better product delivery systems and sustainable product strains. This need has, in turn, led to many companies coming up with R&D, which extensively investigates several genetic improvement strategies for cannabis. While the public opinion of cannabis has gone through many shifts, public interest in Canada has continued to grow in recent years. With the legalization of cannabis in Canada and more research, people are getting a deeper understanding of how cannabis works in humans.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us at info@insights10.com
Rising prevalence of breast cancer pertaining to factors such as prolonged exposure to endogenous oestrogens, early menarche, late age at first childbirth and late menopause will be a high impact rendering factor for the industry growth. Increasing technological advances in cancer biology and launch of several diagnostic and screening programs worldwide should drive the business size. Growing adoption of therapeutics owing to factors such as blocking estrogenic from binding to tumour cells, risk of distant reappearance, lowering jeopardy of reappearance in the breast that had tumour and reducing risk of developing disease in another breast will propel the industry growth.
Growing awareness regarding breast cancer, rising shift towards adoption of western lifestyle, short breast-feeding timeframe and rising prevalence of obesity in women after menopause will drive the industry size. Increasing rate of alcohol consumption in women, rising use of hormone replacement therapy (HRT) and oral birth control pills resulting in increased levels of oestrogen will boost the business size over the forecast period. Growing exposure to certain carcinogens and endocrine disruptors, for example in the workplace, working night shifts results in increased risk are surging up the U.S. market
Prohibitive cost associated with the use of breast cancer therapeutics may hamper the industry growth. Increasing cost of early and late-stage disease therapy, continuing care on a per-unit time basis, accounting for the major share of lifetime cost owing to relatively extended survival of breast cancer patients may further restrain the business growth
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us at info@insights10.com
Epigenetics Diagnostic Market Size, Share, Growth, Trends and Forecast Report...Signitech
The global epigenetics diagnostic market size was valued at USD 5.5 billion in 2018 and is estimated to register a CAGR of 18.8% over the forecast period. Increasing prevalence of cancer and other chronic diseases and growing geriatric population are some of the key factors expected to drive the market.
Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder that impacts an individual ability to focus, self-control, and perform other skills important in daily life. ADHD is caused due to biochemical, connectivity, and the structural difference in the mind. Symptoms of Attention Deficit Hyperactivity Disorder (ADHD) mostly advances over a period and vary according to the type of causing factor and according to the age group of the person. The common symptoms in patient population are trouble at work, low self-esteem and substance abuse or ADHD, low-stress tolerance level, mood swings, and many more. Further, based on symptoms, ADHD is classified into three key categories including the predominantly inattentive, predominantly hyperactive-impulsive, and combined type. ADHD is diagnosed using a comprehensive evaluation of the patient’s mental and behavioral condition. Various treatment options are pharmacological treatment, educational interventions & other behavioral therapies, and EEG biofeedback therapies, physicians could reduce the disorder symptoms and their effects on the individual health.
The global attention deficit hyperactivity disorder (ADHD) market is expected to grow with increasing pharmaceutical R&D spending, growing healthcare expenditure, accelerating economic growth, unmet treatment needs, and mounting occurrence of ADHD. Key trends and developments of this market include progressing drugs under pipeline, high demand for dual therapy, and rising preference for EEG biofeedback therapy. However, there are some factors that can hinder the growth of the market including Medical complications of existing drug therapies, high domination of the generic pharmaceutical market, and strict government protocols
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us at info@insights10.com
Medical Marijuana Market Size, Share, Trends and Growth Analysis Research, 20...Signitech
The global medical marijuana market size was valued at USD 11.4 billion in 2015 and is projected to grow with CAGR of 17.1% during the forecast period.
NON-ALCOHOLIC STEATOHEPATITIS (NASH): AN ANALYSIS OF DISEASE PREVALENCE, DRUG...MP ADVISORS
This report will provide detailed analysis on NASH disease and Drugs in development in broader pharma market. This report list all the drugs in clinical trial and their design and the population recruited, also tells about the pathways representing possible targets for the treatment of NASH
Cancer Diagnostics Global Market estimated to be worth $10,627.4 million by 2026Vinay Shiva Prasad
Increasing prevalence of different types of cancers, increasing awareness of personalized medicine, national program for cancer control by individual countries, availability of companion diagnostics, growth in the point of care testing, increase in sequencing-based tests and other molecular and immunology based techniques are driving the growth of cancer diagnostics.
Global artificial intelligenceGlobal Artificial Intelligence (AI) for Drug Di...GMI Research
Global AI for Drug Discovery Market by Drug Type (Small Molecule and Large Molecules), By Technology (Deep Learning and machine learning), By Therapeutic Type (Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases and Others) End-Users (Pharmaceutical Companies, Biopharmaceutical Companies, Academic and Research Institutes and Others) and by Geography – Opportunities & Forecast, 2018-2025
Charcot Marie tooth disease is one of the hereditary motor and sensory neuropathies, a group of varied inherited disorders of the peripheral nervous system characterized by progressive loss of muscle tissue and touch sensation across various parts of the body.
United states autoimmune disorders diagnostics market report - brochurePharmaion
Pharmaion Consultants offers brochure for "United states autoimmune disorders diagnostics market report" on the base of latest market trends & industry overviews...
The global gene therapy market size was valued at USD 536.43 million in 2018 and is expected to register a CAGR of 33.9% assuming the projected successful commercialization of some of the key therapeutics, that are planned over the forecast period.
Cancer immunotherapies from the perspectives of oncology nursesZeena Nackerdien
This presentation, tailored for oncology nurses, provides an overview of immunotherapy classes, how they work, and how key side effects are typically managed. (Disclaimer: Content is based on peer-reviewed literature; however, it is not a substitute for medical advice. Please consult your doctor)
The us pharmaceutical industry outlook to 2016 sample reportAMMindpower
The present report gives a detailed analysis on the Pharmaceutical market in the US covering various aspects such as market size of the pharmaceutical industry, market segmentation by Branded and Generic drugs, and Prescribed and OTC drugs and Biologics and specialty drugs segments.
Global PCOS Treatment Market Size, Share and Forecast 2025 | TechSci ResearchTechSci Research
According to #TechSci Research report, the Global PCOS Treatment Market valued around USD 3.39 Billion in 2019 and is expected to grow at a formidable rate of around 8.63% during the forecast period.
Report URL - https://bit.ly/3boCto2
Visit our website @ https://www.techsciresearch.com/
For more market research news visit our blog: https://techsciblog.com/
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) Visit us: http://azothanalytics.com/report/healthcare-pharma/global-nuclear-medicine-market-analysis-by-product-type-diagnostic-therapeutic-by-diagnostic-nuclear-medicine-type-by-therapeutic-nuclear-medicine-type-by-indication-by-region-by-country-2019-edition-opportunities-and-forecast-2013-2023-r28197
Global Head and Neck Cancer Therapeutics Market, 2027.pdfTechSci Research
Global Head and Neck Cancer Therapeutics Market stood at USD2024.33 million in 2021 and is expected to grow at an impressive rate of 7.22% during the forecast period. Click : https://bit.ly/3sM7H13
Peptide Based Cancer Therapeutics Market Size Worth $17.18 Billion By 2027 | ...OliviaThomas57
The global peptide based cancer therapeutics market size is expected to reach USD 17.18 billion by 2027 according to a new study by Polaris Market Research
Cancer Diagnostics Global Market estimated to be worth $10,627.4 million by 2026Vinay Shiva Prasad
Increasing prevalence of different types of cancers, increasing awareness of personalized medicine, national program for cancer control by individual countries, availability of companion diagnostics, growth in the point of care testing, increase in sequencing-based tests and other molecular and immunology based techniques are driving the growth of cancer diagnostics.
Global artificial intelligenceGlobal Artificial Intelligence (AI) for Drug Di...GMI Research
Global AI for Drug Discovery Market by Drug Type (Small Molecule and Large Molecules), By Technology (Deep Learning and machine learning), By Therapeutic Type (Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases and Others) End-Users (Pharmaceutical Companies, Biopharmaceutical Companies, Academic and Research Institutes and Others) and by Geography – Opportunities & Forecast, 2018-2025
Charcot Marie tooth disease is one of the hereditary motor and sensory neuropathies, a group of varied inherited disorders of the peripheral nervous system characterized by progressive loss of muscle tissue and touch sensation across various parts of the body.
United states autoimmune disorders diagnostics market report - brochurePharmaion
Pharmaion Consultants offers brochure for "United states autoimmune disorders diagnostics market report" on the base of latest market trends & industry overviews...
The global gene therapy market size was valued at USD 536.43 million in 2018 and is expected to register a CAGR of 33.9% assuming the projected successful commercialization of some of the key therapeutics, that are planned over the forecast period.
Cancer immunotherapies from the perspectives of oncology nursesZeena Nackerdien
This presentation, tailored for oncology nurses, provides an overview of immunotherapy classes, how they work, and how key side effects are typically managed. (Disclaimer: Content is based on peer-reviewed literature; however, it is not a substitute for medical advice. Please consult your doctor)
The us pharmaceutical industry outlook to 2016 sample reportAMMindpower
The present report gives a detailed analysis on the Pharmaceutical market in the US covering various aspects such as market size of the pharmaceutical industry, market segmentation by Branded and Generic drugs, and Prescribed and OTC drugs and Biologics and specialty drugs segments.
Global PCOS Treatment Market Size, Share and Forecast 2025 | TechSci ResearchTechSci Research
According to #TechSci Research report, the Global PCOS Treatment Market valued around USD 3.39 Billion in 2019 and is expected to grow at a formidable rate of around 8.63% during the forecast period.
Report URL - https://bit.ly/3boCto2
Visit our website @ https://www.techsciresearch.com/
For more market research news visit our blog: https://techsciblog.com/
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) Visit us: http://azothanalytics.com/report/healthcare-pharma/global-nuclear-medicine-market-analysis-by-product-type-diagnostic-therapeutic-by-diagnostic-nuclear-medicine-type-by-therapeutic-nuclear-medicine-type-by-indication-by-region-by-country-2019-edition-opportunities-and-forecast-2013-2023-r28197
Global Head and Neck Cancer Therapeutics Market, 2027.pdfTechSci Research
Global Head and Neck Cancer Therapeutics Market stood at USD2024.33 million in 2021 and is expected to grow at an impressive rate of 7.22% during the forecast period. Click : https://bit.ly/3sM7H13
Peptide Based Cancer Therapeutics Market Size Worth $17.18 Billion By 2027 | ...OliviaThomas57
The global peptide based cancer therapeutics market size is expected to reach USD 17.18 billion by 2027 according to a new study by Polaris Market Research
Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Co...Renub Research
Renub Research (http://www.renub.com/report/personalized-medicine-diagnostics-flow-cytometry-sepsis-immunos-routine-coagulation-psychiatric-disorders-tumor-markers-molecular-blood-typing-and-other-testing-116) has announced the addition of the "Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing)" report to its offering
Car-T Cell Therapy Market – Global Industry Size, Share, Trend and Forecast 2...TechSci Research
According to #TechSci Research report, Global Car-T Cell Therapy Market stood at USD1709.00 million in 2021 and is expected to grow at a CAGR of 64.66% during the forecast period.
Gain More Insight: https://bit.ly/3en2NRL
Get Sample Report: https://bit.ly/3EAW5RB
Press Release: https://bit.ly/3vNi06J
Website: https://www.techsciresearch.com/
Market Research News: https://techsciblog.com/
Global clinical nutrition market size, share & Market forecast 2025TechSci Research
According to #TechSci Research latest Report- Global clinical nutrition market is estimated to grow at an impressive rate during the forecast period owing to increasing cases of chronic diseases and increasing awareness pertaining to health and fitness among people.
Report URL- https://www.techsciresearch.com/report/clinical-nutrition-market/4664.html
Colorectal Cancer Market 2023: Epidemiology, Industry Trends, Size, Share And...frankmorgan27
The increasing occurrences of polyps and inflammatory bowel conditions like ulcerative colitis or Crohn’s disease are primarily propelling the colorectal cancer market.
According to www.techsciresearch.com latest Report- The market for animal pharmaceuticals market is likely to grow with a steady CAGR during the forecast period due to the increase in pet adoption, rise in fatal diseases like Ebola and swine flu spreading from consumption of dairy and animal related products.
Report URL- https://www.techsciresearch.com/report/-animal-pharmaceuticals-market/4543.html
Global glycobiology market size, share & market forecast 2025TechSci Research
According to www.techsciresearch.com latest Report- Global glycobiology market is expected to grow at a formidable rate during the forecast period. The global glycobiology market is driven by the growing prevalence of chronic diseases such as cancer, diabetics, renal diseases, among others, which has increased the demand for personalized medicines
Report URL- https://www.techsciresearch.com/report/glycobiology-market/4635.html
The Biologics Market was worth USD 267.58 billion in 2014 and is expected to reach approximately USD 373.66 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 3.78% during the forecast period. Biologics are medicates as hereditarily built proteins, got from human qualities. According to the US FDA, biologics can be made out of sugars, proteins, or nucleic acids or complex blends of these substances, or might live elements, for example, cells and tissues. The biologic medications are taken from an assortment of regular sources, for example, people, creatures, or microorganisms and comprise of items, for example, antibodies, blood and blood parts, allergenic, substantial cells, quality treatment, tissues, and recombinant remedial proteins. Propelled biotechnology strategies and complex procedures are utilized to produce biologics. They are at the cutting edge of biomedical research.
Anal Cancer Market 2023: Epidemiology, Industry Trends, Size, Share And Forec...frankmorgan27
The Anal Cancer Market report thoroughly examines the market size, latest trends, and growth forecast. The report includes an overview of the disease and market scenario, as well as market trends, growth prospects, investment opportunities, and industry prospects. Additionally, it provides competitor analysis, regional analysis, and recent advancements in the Anal Cancer Market.
Cancer Biomarkers Market by Product Type, Distribution Channel, End User 2024...IMARC Group
The global cancer biomarkers market size reached US$ 27.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 77.0 Billion by 2032, exhibiting a growth rate (CAGR) of 11.7% during 2024-2032.
More Info:- https://www.imarcgroup.com/cancer-biomarkers-market
According to #TechSci Research latest Report- The global market for therapeutic plasma exchange is anticipated to grow at brisk rate during the forecast period. Therapeutic plasma exchange or plasmapheresis is a procedure to filter blood and remove harmful antibodies present in plasma by separating it from blood with the assistance of techniques called centrifugation or membrane separation.
Report URL- https://www.techsciresearch.com/report/therapeutic-plasma-exchange-market/4598.html
Haemophilia Treatment Market - Global Industry Size, Share, Trends, Opportuni...TechSci Research
According to #TechSci Research report, Global Haemophilia Treatment Market was valued at USD 13906 million in 2020 and is forecast to reach USD24205 million in 2026 by registering a CAGR of 9.06%.
Gain More Insight: https://bit.ly/3ANFB8k
Get Sample Report: https://bit.ly/3Hn7CGk
Press Release: https://bit.ly/3uhqRNR
Website: https://www.techsciresearch.com/
Market Research News: https://techsciblog.com/
Global carotenoids market is expected to grow at a steady CAGR during the forecast period. The global carotenoids market is driven by the increased product demand from various end user industries such as pharmaceutical industry, cosmetic industry, among others. Click :
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Antifungal Drugs Market. The report analyses the Antifungal Drugs Market By Drug Type (Azoles, Echinocandins, Polyenes, Others), By Therapeutic Indications (Candidiasis, Aspergillosis, Dermatophytosis, Others). The report analyses the Antifungal Drugs Market, By Region (North America, Europe, Asia Pacific, Rest of the World) and By Country (U.S., Canada, Germany, U.K, France, China, Japan, India) for the historical period of 2013-2017 and the forecast period of 2018-2023.Visit us: http://azothanalytics.com/report/healthcare-pharma/global-antifungal-drugs-market-analysis-by-drug-class-azoles-echinocandins-polyenes-others-by-therapeutic-indications-candidiasis-aspergillosis-dermatophytosis-others-by-region-by-country-2019-edition-opportunities-and-forecast-2013-2023-r28194
Similar to Oncology drugs market size, share & forecast 2025 - TechSci Research (20)
India Passenger Car Cabin Air Filter Market, Forecast and Opportunities, 2027...TechSci Research
India passenger car cabin air filter market stood at USD101.45 million in FY2021 and is expected to register growth with a CAGR of approximately 11.69%. http://bit.ly/3MEeQJ5
Saudi Arabia Spare Parts Market, Forecast and Opportunities, 2027.pdfTechSci Research
Saudi Arabia spare parts market generated a value of USD 4,732.85 million in the year 2021 and the market is expected to grow at a CAGR of 6.24% during the forecast. http://bit.ly/3ZO3ZTq
Global Offshore Wind Turbine Market, Forecast and Opportunities, 2027.pdfTechSci Research
Global offshore wind turbine market was valued at USD28.20 billion in 2021 and is anticipated to project robust growth in the forecast period with a CAGR of 13.75% due to high investment and development in the power industry. http://bit.ly/3Wq4TCN
Middle East Facility Management Market was valued at USD 64.27 billion in 2022 and is anticipated to project robust growth during the forecast period, registering a CAGR of 8.13% through 2027. http://bit.ly/3IZ64G4
Final Report_Malaysia Elevators and Escalators Market, 2017-2027F.pptxTechSci Research
Malaysia Elevators & Escalators Market was valued at USD 544.84 million in 2021 and is anticipated to project robust growth in the forecast period with a CAGR of 5.03% owing to the rapid rise in urbanization and increase in infrastructure, making way for the elevators & escalators market. https://www.techsciresearch.com/report/malaysia-elevator-and-escalator-market/7209.html
Global Industrial Valves Market was valued at USD 68,702.45 million in 2022 and is anticipated to grow with a CAGR of 4.96% through 2028. The flow of liquids, gases, and slurries can be managed with the help of industrial valves. http://bit.ly/3XlIUOu
Turkey Medical Tourism market stood at USD1497.07 million in 2021 and is expected to grow at steady rate of 12.23% during the forecast period.
https://www.techsciresearch.com/report/turkey-medical-tourism-market/9418.html
Saudi Arabia Automotive Lead Acid Battery Market Forecast and Opportunities 2...TechSci Research
Saudi Arabia automotive lead acid battery market registered around USD280.80 million in 2021 and is estimated to reach USD437.94 million in 2027, advancing with a CAGR of 8.09%. Rapidly increasing fleet of four-wheelers and escalating fleet size across the country to drive the Saudi Arabia automotive lead acid battery market in the upcoming years.
https://www.techsciresearch.com/report/saudi-arabia-automotive-lead-acid-battery-market/12848.html
The India facility management market stood at USD46.27 billion in 2022 and is forecast to grow at a CAGR of 14.84% by 2028. https://www.techsciresearch.com/report/india-facility-management-market/1383.html
Interview With Dr Karthik Anantharaman From Apollo Hospitals on India E Pharm...TechSci Research
Dr Karthik, Vice President International- Apollo Hospitals, tells TechSci Research that the emergence of new e-pharmacies is good for the industry because even as we speak today, e pharmacy is different, 3% of the total pharmacy market and it's quite similar across the world. Even in the other markets the US or in Western Europe, E pharmacies are among the fastest growing, but still from an overall representation from our value and a top line perspective are still about 3% of the total market or less than 3% of the total market in terms of value. Click : https://www.techsciresearch.com/blog/interview-with-dr-karthik-anantharaman-from-apollo-hospitals-on-india-e-pharmacy-market/1322.html
Indonesia Elevator Market was valued at USD647.96 million in 2021 and is anticipated to project a robust growth in the forecast period with a CAGR of 5.78%. http://bit.ly/3hnPl3A
Global Offshore Oil and Gas Rigs Market Forecast 2027TechSci Research
The Global Offshore Oil & Gas Rig Market valued at USD14735.78 million in 2021 and is anticipated to project robust growth in the forecast period with a CAGR of 5.69% owing to blooming demand for oil and gas, oilfield facilities etc. https://bit.ly/3wdPJGg
India Water Heater Market, Forecast and Opportunities, 2028_Report.pptxTechSci Research
India water heater market is expected to reach USD422.78 million by 2028, growing at a CAGR of 7.16% during the forecast period. The India water heater market is mainly driven by increasing demand from the residential sector, growing per capita income, rising GDP, the increase in sales through online channels, etc. https://bit.ly/3DtyMMM
Global Offshore Oil and Gas Rigs Market, Forecast 2027TechSci Research
The Global Offshore Oil & Gas Rig Market valued at USD14735.78 million in 2021 and is anticipated to project robust growth in the forecast period with a CAGR of 5.69% owing to blooming demand for oil and gas, oilfield facilities etc.https://bit.ly/3wdPJGg
Saudi Arabia Automotive Aftermarket, Forecast and Opportunities, 2027_Report.pdfTechSci Research
Saudi Arabia Automotive Aftermarket registered market value of USD6,490.35 million in 2021 and is estimated to reach USD9446.95 million in 2027, advancing with a CAGR of 6.43%. https://bit.ly/3RYgx6O
Saudi Arabia Electric Vehicle Charging Infrastructure Market 2027.pdfTechSci Research
Saudi Arabia electric vehicle charging infrastructure market is anticipated to register a robust CAGR during the forecast period, 2023-2027. Increasing sales of electric vehicles and favorable government initiatives are the primary factors driving the growth of Saudi Arabia electric vehicle charging infrastructure market.
Middle East and Africa Electric Three-Wheeler Market, 2027.pdfTechSci Research
Middle East and Africa Electric three-wheeler market stood at USD15,748.91 thousand in 2021 and is forecast to grow at a CAGR of 14.38% to reach USD50,808.07 thousand by 2030. https://bit.ly/3wM0Gyk
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
2. 2
Scope of Report
Product of Interest (POI): Oncology Drugs
Review Period
2015 – 2018
Base Year
2019
Estimated Year
2020
Forecast Period
2021 – 2025
Year Range
REGION
• Asia-Pacific
• Europe
• North America
• South America
• Middle East & Africa
Global oncology drugs market is projected to grow at a brisk rate over the forecast period owing to
widespread prevalence of cancer, globally. Various other related factors which are contributing to the
growth of oncology drugs market include rise in geriatric population worldwide, increase in global
healthcare expenditure, rising number of product approvals by regulatory bodies and growing R&D
activities for the development of new cancer drugs. Furthermore, emergence of biosimilar products for
cancer treatment, increasing collaborations between pharmaceutical companies and development of
pipeline oncology products are providing opportunities for various oncology drug manufacturers.
Market Segmentation
THERAPY
• Chemotherapy
• Targeted Therapy
• Immunotherapy
(Biologic Therapy)
• Hormonal Therapy
• Others
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Government Hospitals
DISTRIBUTION
CHANNEL
CANCER TYPE
• Lung Cancer
• Stomach Cancer
• Colorectal Cancer
• Breast Cancer
• Prostate Cancer
• Liver Cancer
• Esophagus Cancer
• Cervical Cancer
• Kidney Cancer
• Bladder Cancer
• Others
DRUG TYPE
• Cytotoxic Drugs
• Targeted Drugs
• Hormonal Drugs
GENDER
• Male
• Female
DRUG THERAPY
• Adjuvant
• Neoadjuvant
• Concurrent
ROUTE OF ADMINISTRATION
• Oral
• Intravenous
• Subcutaneous
• Others
3. 3
Table of Contents
S. No. Contents Page No.
1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global Oncology Drugs Market
4. Executive Summary
5. Voice of Customer
6. Global Oncology Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Type (Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs)
6.2.2.
By Therapy (Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal
Therapy, Others)
6.2.3. By Drug Therapy (Adjuvant, Neoadjuvant and Concurrent)
6.2.4. By Route of Administration (Oral, Intravenous, Subcutaneous, Others)
6.2.5. By Gender (Male, Female)
6.2.6.
By Cancer Type (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate
Cancer, Liver Cancer, Esophagus Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer,
Others)
6.2.7.
By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies,
Government Hospitals)
6.2.8. By Company (2019)
6.2.9. By Region (Asia-Pacific, Europe, North America, South America and Middle East &
Africa)
6.3. Product Market Map
4. 4
Table of Contents
S. No. Contents Page No.
7. Asia-Pacific Oncology Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drug Type
7.2.2. By Therapy
7.2.3. By Drug Therapy
7.2.4. By Route of Administration
7.2.5. By Gender
7.2.6. By Cancer Type
7.2.7. By Country (China, India, Australia, Japan, South Korea)
7.3. Asia-Pacific: Country Analysis
7.3.1. China Oncology Drugs Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Drug Type
7.3.1.2.2. By Therapy
7.3.1.2.3. By Drug Therapy
7.3.1.2.4. By Route of Administration
7.3.1.2.5. By Gender
7.3.1.2.6. By Cancer Type
5. 5
Table of Contents
S. No. Contents Page No.
7.3.2. India Oncology Drugs Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Drug Type
7.3.2.2.2. By Therapy
7.3.2.2.3. By Drug Therapy
7.3.2.2.4 By Route of Administration
7.3.2.2.5. By Gender
7.3.2.2.6. By Cancer Type
7.3.3. Australia Oncology Drugs Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Drug Type
7.3.3.2.2. By Therapy
7.3.3.2.3. By Drug Therapy
7.3.3.2.4. By Route of Administration
7.3.3.2.5. By Gender
7.3.3.2.6. By Cancer Type
6. 6
Table of Contents
S. No. Contents Page No.
7.3.4. Japan Oncology Drugs Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Drug Type
7.3.4.2.2. By Therapy
7.3.4.2.3. By Drug Therapy
7.3.4.2.4 By Route of Administration
7.3.4.2.5. By Gender
7.3.4.2.6. By Cancer Type
7.3.5. Australia Oncology Drugs Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Drug Type
7.3.5.2.2. By Therapy
7.3.5.2.3. By Drug Therapy
7.3.5.2.4. By Route of Administration
7.3.5.2.5. By Gender
7.3.5.2.6. By Cancer Type
7. 7
Table of Contents
S. No. Contents Page No.
8. Europe Oncology Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drug Type
8.2.2. By Therapy
8.2.3. By Drug Therapy
8.2.4. By Route of Administration
8.2.5. By Gender
8.2.6. By Cancer Type
8.2.7. By Country (France, Germany, United Kingdom, Italy, Spain)
8.3. Asia-Pacific: Country Analysis
8.3.1. France Oncology Drugs Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Drug Type
8.3.1.2.2. By Therapy
8.3.1.2.3. By Drug Therapy
8.3.1.2.4. By Route of Administration
8.3.1.2.5. By Gender
8.3.1.2.6. By Cancer Type
8. 8
Table of Contents
S. No. Contents Page No.
8.3.2. Germany Oncology Drugs Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Drug Type
8.3.2.2.2. By Therapy
8.3.2.2.3. By Drug Therapy
8.3.2.2.4 By Route of Administration
8.3.2.2.5. By Gender
8.3.2.2.6. By Cancer Type
8.3.3. United Kingdom Oncology Drugs Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Drug Type
8.3.3.2.2. By Therapy
8.3.3.2.3. By Drug Therapy
8.3.3.2.4. By Route of Administration
8.3.3.2.5. By Gender
8.3.3.2.6. By Cancer Type
9. 9
Table of Contents
S. No. Contents Page No.
8.3.4. Italy Oncology Drugs Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Drug Type
8.3.4.2.2. By Therapy
8.3.4.2.3. By Drug Therapy
8.3.4.2.4 By Route of Administration
8.3.4.2.5. By Gender
8.3.4.2.6. By Cancer Type
8.3.5. Spain Oncology Drugs Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Drug Type
8.3.5.2.2. By Therapy
8.3.5.2.3. By Drug Therapy
8.3.5.2.4. By Route of Administration
8.3.5.2.5. By Gender
8.3.5.2.6. By Cancer Type
10. 10
Table of Contents
S. No. Contents Page No.
9. North America Oncology Drugs Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Drug Type
9.2.2. By Therapy
9.2.3. By Drug Therapy
9.2.4. By Route of Administration
9.2.5. By Gender
9.2.6. By Cancer Type
9.2.7. By Country (United States, Mexico, Canada)
9.3. North America: Country Analysis
9.3.1. United States Oncology Drugs Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Drug Type
9.3.1.2.2. By Therapy
9.3.1.2.3. By Drug Therapy
9.3.1.2.4. By Route of Administration
11. 11
Table of Contents
S. No. Contents Page No.
9.3.1.2.5. By Gender
9.3.1.2.6. By Cancer Type
9.3.2. Mexico Oncology Drugs Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Drug Type
9.3.2.2.2. By Therapy
9.3.2.2.3. By Drug Therapy
9.3.2.2.4 By Route of Administration
9.3.2.2.5. By Gender
9.3.2.2.6. By Cancer Type
9.3.3. Canada Oncology Drugs Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Drug Type
9.3.3.2.2. By Therapy
9.3.3.2.3. By Drug Therapy
9.3.3.2.4. By Route of Administration
9.3.3.2.5. By Gender
9.3.3.2.6. By Cancer Type
12. 12
Table of Contents
S. No. Contents Page No.
10. South America Oncology Drugs Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Drug Type
10.2.2. By Therapy
10.2.3. By Drug Therapy
10.2.4. By Route of Administration
10.2.5. By Gender
10.2.6. By Cancer Type
10.2.7. By Country (Brazil, Argentina, Colombia)
10.3. South America: Country Analysis
10.3.1. Brazil Oncology Drugs Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Drug Type
10.3.1.2.2. By Therapy
10.3.1.2.3. By Drug Therapy
10.3.1.2.4. By Route of Administration
13. 13
Table of Contents
S. No. Contents Page No.
10.3.1.2.5. By Gender
10.3.1.2.6. By Cancer Type
10.3.2. Argentina Oncology Drugs Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Drug Type
10.3.2.2.2. By Therapy
10.3.2.2.3. By Drug Therapy
10.3.2.2.4 By Route of Administration
10.3.2.2.5. By Gender
10.3.2.2.6. By Cancer Type
10.3.3. Colombia Oncology Drugs Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Drug Type
10.3.3.2.2. By Therapy
10.3.3.2.3. By Drug Therapy
10.3.3.2.4. By Route of Administration
10.3.3.2.5. By Gender
10.3.3.2.6. By Cancer Type
14. 14
Table of Contents
S. No. Contents Page No.
11. Middle East and Africa Oncology Drugs Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Drug Type
11.2.2. By Therapy
11.2.3. By Drug Therapy
11.2.4. By Route of Administration
11.2.5. By Gender
11.2.6. By Cancer Type
11.2.7. By Country (South Africa, Saudi Arabia, UAE, Kuwait)
11.3. Middle East and Africa: Country Analysis
11.3.1. South Africa Oncology Drugs Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Drug Type
11.3.1.2.2. By Therapy
11.3.1.2.3. By Drug Therapy
11.3.1.2.4. By Route of Administration
15. 15
Table of Contents
S. No. Contents Page No.
11.3.1.2.5. By Gender
11.3.1.2.6. By Cancer Type
11.3.2. Saudi Arabia Oncology Drugs Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Drug Type
11.3.2.2.2. By Therapy
11.3.2.2.3. By Drug Therapy
11.3.2.2.4 By Route of Administration
11.3.2.2.5. By Gender
11.3.2.2.6. By Cancer Type
11.3.3. UAE Oncology Drugs Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Drug Type
11.3.3.2.2. By Therapy
11.3.3.2.3. By Drug Therapy
11.3.3.2.4. By Route of Administration
11.3.3.2.5. By Gender
11.3.3.2.6. By Cancer Type
16. 16
Table of Contents
S. No. Contents Page No.
11.3.4. Kuwait Oncology Drugs Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Drug Type
11.3.4.2.2. By Therapy
11.3.4.2.3. By Drug Therapy
11.3.4.2.4. By Route of Administration
11.3.4.2.5. By Gender
11.3.4.2.6. By Cancer Type
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
15. Strategic Recommendations
16. About Us & Disclaimer
18. 18
Research Methodology
Identifying Key Opinion
Leaders
Questionnaire Design
In-depth Interviews
Data
Collection
Developing List
of Respondents
Formulating
Questionnaire
Market
Profiling
Data
Validation
Data
Analysis
In-depth secondary
research was conducted to
determine top players in
the global oncology drugs
market, overall market size
and segmental market size.
In order to conduct
industry experts’
interviews, TechSci
formulated a detailed
discussion guide.
List of industry
players and industry
specialists was
developed.
TechSci conducted
interviews with
industry experts and
industry players for
data collection and
verification.
Data obtained as a
result of primary
and secondary
research was
validated through
rigorous
triangulation.
The data was scrutinized
using MS-Excel, statistical
tools and internal
proprietary database to
obtain qualitative and
quantitative insights about
the global oncology drugs
market.
Data
Collection
Data Filter
& Analysis
Research &
Intelligence
Actionable
Insights
Business
Solution
Primary Research Desk Research Company Analysis
Recent Developments
Market Changing
Aspects/Dynamics
Government Policies
Conclusion
Market Participants
Key Strengths
LinkedIn
TechSci Internal
Database
Factiva
Hoovers
Paid Sources
Company Websites
Company Annual
Reports
White Paper Study
Financial Reports
Investor
Presentations
Regulatory Body
Associations, etc.
Secondary
Research
Primary Research
19. 19
Research Methodology
Baseline Methodology
Our dedicated team of industry experts has monitored and analyzed various aspects of the global oncology drugs market. The team has
market, while considering the major influencing factors such as growing R&D activities for the development of new cancer drugs. The
enable our clients to take better decisions while planning their strategy to achieve sustainability in the global oncology drugs market.
Methodology Followed for Calculation of Market Size:
• Market Size by Value: Market size, in terms of value, for the year 2019 was calculated based on information collected through
exhaustive secondary research and primary surveys, with various key opinion leaders/stakeholders, such as oncology drugs
users, industry experts, and other industry participants.
• The team interviewed more than 15 – 20 oncology drugs companies, 100 – 120 end-users, and 15 – 20 industry experts and other
drugs market to obtain the overall market size from 2015 to 2019, which was validated by the Delphi technique. Taking standard
averaged out, to arrive at the market size data during 2015-2019.
20. 20
Research Methodology
• Respondents were asked about the current and future market growth rates, market shares by drug type, by therapy, by drug therapy, by route of administration, by gender, by cancer
type, by distribution channel, by company and by region. Removing the outlier responses, the geometric mean of growth estimates and provider wise revenue shares generated
across various segments were considered, to arrive at the final revenue shares. Revenue shares generated across various segments were further triangulated from other
stakeholders.
Methodology Followed for Calculation of Market Shares:
• Market share by drug type, by therapy, by drug therapy, by route of administration, by gender, by cancer type, by distribution channel, by company and by region were calculated
based on the responses received through primary surveys with industry experts, in which the respondents were asked about the market shares or revenue generated from various
segments of oncology drugs markets. The final shares were calculated by taking the geometric mean of the responses gathered from key opinion leaders after eliminating the
outliers.
Methodology Followed for Forecasting:
• TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey results in SPSS/Tableau Software.
• Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast global oncology drugs market, TechSci Research used
various forecast techniques such as:
Moving Average
Time Series Analysis
Regression Analysis
Econometric and Judgmental Analysis
21. 21
Research Methodology
TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research also used the impact analysis during
short, medium and long term period to estimate the demand and to reach accurate market numbers. It should be noted that the figures compiled are only for the organized market
including market share data. The currency used in the report is the United States Dollar (USD), with the market size indicated in USD million.
Partial List of Companies Interviewed Key Secondary Sources
• Abbott Laboratories
• AbbVie Inc
• Roche Holding AG
• Novartis International AG
• Johnson & Johnson
• Bristol-Myers Squibb Company
• Celgene Corporation
• Merck & Co., Inc
• Pfizer Inc.
• Eli Lilly
• AstraZeneca PLC
• Takeda Pharmaceutical
• Amgen
• Astellas Pharma
• Sanofi SA
• Eisai
• Thermo Fisher Scientific
• Astex Pharmaceutical
• Daiichi Sankyo
• Teva Pharmaceutica
World Bank
TechSci Research Proprietary Database & Knowledge Repository
Company Annual Reports
Industry Magazines
Industry Reports
News Dailies
Credible Paid Databases
22. 22
INDUSTRY BRIEF
According to TechSci Research report, “Global Oncology Drugs Market By Drug Type, By Therapy, By Drug Therapy, By Route of Administration, By Gender, By Cancer Type, By Distribution
Channel, By Region, Competition, Forecast & Opportunities, 2025”, the global oncology drug market is anticipated to continue following its growth trajectory through 2025 due to rising prevalence of
cancer worldwide, increasing geriatric population and growing healthcare expenditure. Other key drivers behind the growth of this market are increasing number drug approvals, emergence of
biosimilar products for cancer treatment, growing research & development activities for developing new cancer drugs and increasing governments' expenditure on healthcare infrastructure.
The fatal nature of cancer and low rate of success for treatments, has compelled medical practitioners to conduct new research methodologies for better and advanced treatments. Population in
various developed countries like the US are projected to become increasingly aged and show rising obesity incidence, which will drive both cancer prevalence and consequently revenue growth for
its treatments in the coming years. But apart from the factors leading to growth of oncology drugs market, there are some restrains as well. The side effects and long-term sequelae of anti-cancer
chemotherapy tend to impede the market growth. Also, adverse effects of oncology drugs and expensive treatments pose hindrance to the growth of the market, globally.
The global oncology drugs market is segmented based on drug type, therapy, drug therapy, route of administration, gender, cancer type, distribution channel and region. Based on drug type, the
market is segmented into cytotoxic drugs, targeted drugs and hormonal drugs. The targeted therapy and chemotherapy segments cumulatively hold majority share in the global oncology drugs
market. The targeted therapy kills only malignant cells and has good survival rates. However, the immunotherapy segment is expected to register the highest growth rate during the forecast period
owing to higher rates of survival and remission related to their use.
Based on cancer type, the market is segmented into lung cancer, stomach cancer, colorectal cancer, breast cancer, prostate cancer, liver cancer, esophagus cancer, cervical cancer, kidney cancer,
bladder cancer and others. The lung cancer segment holds the largest share in the global oncology drugs market due to high prevalence of the disease, globally. AbbVie Inc, Roche Holding AG,
Novartis International AG, Johnson & Johnson, Bristol-Myers Squibb Company, Celgene Corporation, Merck & Co., Inc, Pfizer Inc., Eli Lilly, AstraZeneca PLC, Takeda Pharmaceutical, Amgen,
Astellas Pharma, Sanofi SA , Eisai Inc., Abbott Laboratories, Thermo Fisher Scientific, Astex Pharmaceutical, Daiichi Sankyo and Teva Pharmaceutical are some of the leading players operating in
global oncology drugs market. Key manufacturers are trying to focus on introducing more personalized medicines to target cancer treatment and thereby enhance their market share. They are also
focusing on strategies such as mergers with research institutes and acquisition of small market players in order to grab higher market share.
“North American players hold a strong dominance in the global oncology drugs market as they have better medical treatment options available and companies out there have a significantly higher
focus on R&D activities. US and Canada register highest survival rate during the course of cancer treatment. Increasing product approvals by regulatory bodies for the treatment of various cancers is
also positively impacting the market. Altogether, the future of global oncology drugs market is bright with development of pipeline oncology products and expiry of key patents providing opportunities
for drug manufacturers.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
23. 23
SAMPLE DATA - SNAPSHOT
Global Oncology Drugs Market Size, By Value (USD Million), 2015-2025F
5.00 6.00 7.00 8.00 9.00 10.00 11.00 12.00 13.00 14.00 15.00
2015 2019 2020E 2025F
By Value (USD Million)
CAGR By Value CAGR By Value
XX% YY%
North America Oncology Drugs Market Share, By Drug Type, By Value, 2015–2025F
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
34%
34%
34%
34%
34%
34%
34%
34%
34%
34%
34%
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
2015
2016
2017
2018
2019
2020E
2021F
2022F
2023F
2024F
2025F
Cytotoxic Drugs Targeted Drugs Hormonal Drugs
United States Oncology Drugs Market Share, By Route of Administration, By Value, 2015–2025F
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
2015
2016
2017
2018
2019
2020E
2021F
2022F
2023F
2024F
2025F
Oral Intravenous Subcutaneous Others
24. 24
REPORT ORDERING
License Type Price
Electronic Access - Single User License $4450
Electronic Access - Multi-User License $5450
Custom Research License $9450
Report Price
To View Sample OR Purchase Report
Report Name: GLOBAL ONCOLOGY DRUGS MARKET
FORECAST & OPPORTUNITIES
2015 – 2025
25. About Us & Disclaimer
TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in
number of areas to organizations. The company uses innovative business Modes that focus on improving productivity, while ensuring creation of high-quality
of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ Mode of a country, regional and global industry
activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the market.
Related Reports
• Global Clinical Diagnostics Market By Virus Type of Test (Lipid Panel, Metabolic Panel, Infectious Disease Testing, Others), By Virus Type
(Instruments, Reagents, Assays and Kits, Software), By Genetic Information (Infectious Disease (COVID-19, Sepsis, HIV , Others), Cardiology,
Cancer), By Region, Competition, Forecast & Opportunities, 2025
• Global Electronic Skin Patches Market By Genetic Information (Cardiovascular Monitoring, Wireless Inpatient Monitoring, Diabetes Management,
Iontophoresis Skin patches, Sweat Sensing), By Material (Silicon Based, Polymer Based and Others), By Test Type (Disposable and Reusable), By
End User (Hospitals, Ambulatory Surgical Centers and Others), By Region, Forecast & Opportunities, 2025
The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely,
accurate or complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it
considers reliable and firsthand. However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible
for any errors or omissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the
subscribers / users of this report. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this
document are indicative of relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior
approval of TechSci Research.
TechSci Research – North America
708 Third Avenue, Manhattan,
New York, United States
Tel: +1- 646- 360- 1656
Email: sales@techsciresearch.com
www.techsciresearch.com
Disclaimer
TechSci Research – Europe
54, Old brook, Bretton,
Peterborough,
United Kingdom
Email: sales@techsciresearch.com
www.techsciresearch.com
TechSci Research – Asia-Pacific
B – 44, Sector – 57, Noida, National Capital
Region, U.P. - India
Tel: +91-120-4523900
Email: sales@techsciresearch.com
www.techsciresearch.com